|Ms. Belen Garijo Lopez M.D.||Chair of Exec. Board & CEO||5M||N/A||1960|
|Dr. Marcus Kuhnert||CFO & Member of Exec. Board||4.07M||N/A||1968|
|Dr. Kai Beckmann||CEO of Electronics & Member of the Exec. Board||4.15M||N/A||1965|
|Mr. Peter Guenter||CEO of Healthcare Bus. & Member of Exec. Board||N/A||N/A||1962|
|Dr. Matthias J. Heinzel||CEO of Life Science Sector & Member of Exec. Board||N/A||N/A||1967|
|Mr. Gerhard Schmitz||Head of Global Accounting||N/A||N/A||1963|
|Mr. Dirk Toepfer||Chief Information Officer||N/A||N/A||N/A|
|Mr. Constantin Fest||Head of Investor Relations||N/A||N/A||1977|
|Dr. Friederike Rotsch||Group Gen. Counsel and Head of Group Legal & Compliance||N/A||N/A||1972|
|Ms. Barbara Weiland||Chief Compliance Officer||N/A||N/A||1974|
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd., Artios Pharma Limited, CytoReason, and Inbrain Neuroelectronics S.L. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
MERCK Kommanditgesellschaft auf Aktien’s ISS Governance QualityScore as of September 26, 2021 is 10. The pillar scores are Audit: 3; Board: 7; Shareholder Rights: 10; Compensation: 9.